Figure 1From: Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profilingMAPD of 162 samples ran in triplicate across three laboratories with the Affymetrix OncoScan® assay. The inter-sample MAPD variance is larger than the mean of the intra-sample MAPD variances. These inter-sample MAPD differences are governed by inherent properties of the samples.Back to article page